BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.16B |
| 2 |
AbbVie
ABBV
|
+$1.93B |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$1.81B |
| 4 |
Otis Worldwide
OTIS
|
+$1.67B |
| 5 |
Carrier Global
CARR
|
+$1.43B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$3.74B |
| 2 |
RTN
Raytheon Company
RTN
|
+$2.93B |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$1.67B |
| 4 |
CY
Cypress Semiconductor
CY
|
+$779M |
| 5 |
iShares MBS ETF
MBB
|
+$772M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.92% |
| 2 | Healthcare | 14.84% |
| 3 | Financials | 12.13% |
| 4 | Consumer Discretionary | 10.93% |
| 5 | Communication Services | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
BCB Bancorp
BCBP
$158M
| $7.62M | ﹤0.01% |
821,493
-39,097
| -5% | -$375K |
|
|
CLPR
3327
Clipper Realty
CLPR
$47M
| $7.61M | ﹤0.01% |
939,513
+97,880
| +12% | +$614K |
|
3328
iShares iBonds Dec 2030 Term Corporate ETF
IBDV
$3.3B
| $7.59M | ﹤0.01% |
+300,000
| New | +$7.57M |
|
3329
Research Frontiers
REFR
$17.2M
| $7.59M | ﹤0.01% |
1,869,629
+1,143,242
| +157% | +$4.24M |
|
3330
Wrap Technologies
WRAP
$104M
| $7.58M | ﹤0.01% |
723,605
+260,534
| +56% | +$1.56M |
|
3331
Escalade
ESCA
$286M
| $7.54M | ﹤0.01% |
540,432
-4,778
| -0.9% | -$44.3K |
|
3332
First Business Financial Services
FBIZ
$597M
| $7.54M | ﹤0.01% |
458,499
-15,233
| -3% | -$238K |
|
3333
Atlanticus Holdings
ATLC
$1.42B
| $7.5M | ﹤0.01% |
724,933
+160,922
| +29% | +$2.14M |
|
3334
Xeris Biopharma Holdings
XERS
$1.53B
| $7.49M | ﹤0.01% |
2,814,848
+478,430
| +20% | +$1.67M |
|
3335
CALL
VanEck Gold Miners ETF
GDX
$27.5B
| $7.46M | ﹤0.01% |
+203,500
| New | +$6.69M |
|
3336
Genco Shipping & Trading
GNK
$1.08B
| $7.46M | ﹤0.01% |
1,188,187
+76,908
| +7% | +$445K |
|
|
BMY.RT
3337
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $7.46M | ﹤0.01% |
2,084,875
-50,665
| -2% | -$183K |
|
3338
Sutro Biopharma
STRO
$415M
| $7.45M | ﹤0.01% |
96,024
+29,949
| +45% | +$2.87M |
|
|
NESR
3339
National Energy Services Reunited Corp
NESR
$3.63B
| $7.39M | ﹤0.01% |
1,074,598
-132,136
| -11% | -$708K |
|
3340
FS Bancorp
FSBW
$322M
| $7.38M | ﹤0.01% |
382,430
-52,504
| -12% | -$1.02M |
|
|
HBMD
3341
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
| $7.36M | ﹤0.01% |
693,574
-46,293
| -6% | -$472K |
|
3342
Crawford & Co Class A
CRD.A
$640M
| $7.36M | ﹤0.01% |
932,345
+27,313
| +3% | +$185K |
|
|
SBBP
3343
DELISTED
Strongbridge Biopharma plc.
SBBP
| $7.36M | ﹤0.01% |
1,945,893
-115,089
| -6% | -$345K |
|
3344
Norwood Financial Corp
NWFL
$373M
| $7.35M | ﹤0.01% |
296,717
-13,437
| -4% | -$319K |
|
|
FARM
3345
DELISTED
Farmer Brothers
FARM
| $7.34M | ﹤0.01% |
1,000,605
+215,654
| +27% | +$1.73M |
|
3346
MVB Financial
MVBF
$392M
| $7.32M | ﹤0.01% |
550,486
+12,170
| +2% | +$163K |
|
3347
BayCom
BCML
$341M
| $7.3M | ﹤0.01% |
565,848
-9,736
| -2% | -$120K |
|
3348
Ituran Location and Control
ITRN
$1.04B
| $7.24M | ﹤0.01% |
452,003
-16,055
| -3% | -$264K |
|
|
CFRX
3349
DELISTED
ContraFect Corporation
CFRX
| $7.23M | ﹤0.01% |
14,148
+14,049
| +14,191% | +$6.9M |
|
3350
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7.75B
| $7.21M | ﹤0.01% |
261,174
-8,015
| -3% | -$210K |
|
Similar funds
BlackRock's Q2 2020 Portfolio in Review
As of Q2 2020, BlackRock held 5,263 positions worth $2.51T, up 23% from $2.04T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q2 2020 filing shows 247 new, 2,443 increased, 1,910 reduced and 215 closed positions. Its largest new stake was Otis Worldwide: 32,136,910 shares worth $1.83B. The largest sale was Allergan plc, an estimated $3.74B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2020 buy was Otis Worldwide: 32,136,910 shares worth $1.83B.
- BlackRock added most to Amazon in Q2 2020, an estimated $2.16B increase.
- BlackRock's biggest Q2 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $1.67B.
- BlackRock fully exited Allergan plc in Q2 2020, selling an estimated $3.74B.
- BlackRock's ten largest holdings make up 19% of its $2.51T portfolio in Q2 2020.
- BlackRock opened 247 new positions and closed 215 in Q2 2020.
- BlackRock's portfolio value rose 23% quarter-over-quarter to $2.51T.
Based on BlackRock's 13F filing for Q2 2020, filed 14 Aug 2020.